Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
Interview with the Innovators
Filter by Topic
PMO Interview with the Innovator Series
Smart Patients: The Power of Sharing Personal Health Experiences
An Interview with Roni Zeiger, MD, of Smart Patients
Interview with the Innovators
Read More ›
A New Approach to Cell Culturing
An Interview with James Lim, PhD, of Xcell Biosciences
Interview with the Innovators
Read More ›
Prevention Is the Key to Bone Health in Patients with Prostate Cancer
An interview with The Urology Group, Cincinnati, OH
Interview with the Innovators
Read More ›
Early Recurrence Detection: Analyzing DNA from Circulating Tumor Cells and Circulating Cell-Free DNA
An Interview with Paul W. Dempsey, PhD, and Paul Y. Song, MD, of Cynvenio
Interview with the Innovators
Read More ›
Oncology Nurse Navigators: A Growing Trend in Oncology Practices Proving to Play a Critical Role in Patient Care
An Interview with Lillie D. Shockney, RN, BS, MAS, of Johns Hopkins University
Interview with the Innovators
Read More ›
NCI-MATCH: A Paradigm Shift in the Evolution of Personalized Medicine Trials
An Interview with Douglas R. Lowy, MD, of the National Cancer Institute
Interview with the Innovators
Read More ›
Personalizing Oncology Care and the Quest for Companion Diagnostics: A Researcher’s Perspective
An Interview with Suso J. Platero, PhD, of Janssen Pharmaceuticals
By
Suso J. Platero, PhD
Interview with the Innovators
Read More ›
Cancer Stem Cell Research: A New Frontier in the Fight Against Cancer:
An Interview with Stanton L. Gerson, MD, Case Comprehensive Cancer Center, and Zev A. Wainberg, MD, University of California, Los Angeles
Interview with the Innovators
Read More ›
The Current Landscape in Melanoma Treatment
Interview with the Innovators
Read More ›
High-Dose Interleukin-2 as a Second-Line Option in Metastatic Melanoma
Interview with the Innovators
Read More ›
Page 1 of 5
1
2
3
4